Literature DB >> 29884411

Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis.

Nosayaba Osazuwa-Peters1, Lauren D Arnold2, Travis M Loux3, Mark A Varvares4, Mario Schootman3.   

Abstract

OBJECTIVES: Cancer diagnosis is considered an independent predictor of suicide. We aimed to determine whether gender and human papillomavirus (HPV)-relatedness are associated with increased risks of suicide in the head and neck cancer (HNC) population.
MATERIALS AND METHODS: Adult patients ≥18 years with HNC were selected using the Surveillance, Epidemiology, and End Results (SEER) data from 1973 to 2014. Using anatomic sites as proxy, patients were grouped as HPV-related or not HPV-related. Standardized Mortality Ratios (SMRs) were calculated, and association between suicide, gender, HPV-relatedness were estimated as adjusted rate ratios (aRR) using multivariable Poisson regression model.
RESULTS: There were 1036 suicides among 287,901 HNC patients in the study period (63 suicides per 100,000 person-years). Male patients were six times more likely to commit suicide compared to female patients (aRR = 5.74, 95% CI 3.88, 8.50); however, HPV-relatedness did not increase risk of suicide (aRR = 0.87, 95% CI 0.58, 1.29). Compared with white patients, blacks (aRR = 0.20, 95% CI 0.12, 0.33) and Hispanics (aRR = 0.25, 95% CI 0.14, 0.43) were less likely to commit suicide. Additionally, increased risks of suicide were found among the widowed (aRR = 1.48, 95% CI 1.10, 1.99) and divorced/separated (aRR = 1.30, 95% CI 1.00, 1.69), compared with married patients.
CONCLUSION: Gender, not HPV-relatedness, was associated with risk of suicide in our study. We identified HNC patients more likely to commit suicide as: previously married, white, male, widowed, divorced or separated, ≥70 years. Our findings may be useful clinically in planning personalized cancer care and lifelong surveillance of HNC patients with higher risks of suicide.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer survivorship; Gender; HPV-relatedness; Head and neck cancer; SEER; Suicide

Mesh:

Year:  2018        PMID: 29884411     DOI: 10.1016/j.oraloncology.2018.03.017

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

Review 1.  State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes.

Authors:  Sara C Parke; David Michael Langelier; Jessica Tse Cheng; Cristina Kline-Quiroz; Michael Dean Stubblefield
Journal:  Curr Oncol Rep       Date:  2022-02-19       Impact factor: 5.075

2.  Forecast of peak attainment and imminent decline after 2017 of oral cancer incidence in men in Taiwan.

Authors:  Jing-Rong Jhuang; Shih-Yung Su; Chun-Ju Chiang; Ya-Wen Yang; Li-Ju Lin; Tsui-Hsia Hsu; Wen-Chung Lee
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

3.  Comparison of prevalence and associated factors of depressive disorder between patients with head and neck cancer and those with lung cancer at a tertiary hospital in Taiwan: a cross-sectional study.

Authors:  Yu Lee; Chi-Fa Hung; Chih-Yen Chien; Pao-Yen Lin; Meng-Chih Lin; Chin-Chou Wang; Hung-I Lu; Yung-Che Chen; Mian-Yoon Chong; Liang-Jen Wang
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

4.  Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays.

Authors:  Ozgen Ahmet Yildirim; Kerem Poyraz; Erkan Erdur
Journal:  Qual Life Res       Date:  2021-02-26       Impact factor: 4.147

5.  Health-related quality of life in head and neck cancer survivors: Evaluating the rural disadvantage.

Authors:  Jenna L Adamowicz; Alan Christensen; M Bryant Howren; Aaron T Seaman; Nicholas D Kendell; Shylo Wardyn; Nitin A Pagedar
Journal:  J Rural Health       Date:  2021-03-15       Impact factor: 5.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.